Articles tagged with Parasites
A study published in Ecology found that parasite prevalence and diversity increase with higher latitude, challenging the typical latitudinal diversity gradient. This exception suggests that local ecological factors play a role in shaping biodiversity, despite the general pattern of decreasing species richness towards the poles.
A new anti-basigin drug has cured mice of established malaria infection with minimal side effects, offering hope for treating the deadly disease. The drug's development path may be less complex than traditional clinical trials, as it builds on existing knowledge of the protein's role in cancer and graft-versus-host disease.
Scientists have identified a potent agent, DSM265, that thwarts drug resistance in malaria parasites. This breakthrough treatment has the potential to be used for both single-dose and once-weekly doses, offering new hope against the disease.
Researchers found that existing malaria infections in mosquitoes facilitate replication of secondary infections, leading to higher parasite loads. This could disproportionately contribute to malaria transmission, especially if control measures focus on reducing mosquito feedings.
Researchers at the University of Georgia have developed new tools to study and genetically manipulate cryptosporidium, a major cause of life-threatening diarrhea in infants and toddlers. The breakthrough techniques will help find new treatments and vaccines for the parasite.
University of Washington chemists have developed a novel drug to fight malaria, DSM265, which targets the critical protein DHODH. The compound has shown promise in laboratory tests and is suitable for clinical trials in humans.
Scientists have identified a key protein that, if targeted, can stop the disease. The discovery could lead to precise drug design with limited toxicity, making it safe for vulnerable populations.
Researchers will study the complex interaction of human and natural forces that may alter patterns of disease transmission. Small prawns are expected to kill snails effectively, providing a potential solution to schistosomiasis.
Researchers developed targeted nanoparticles that deliver existing drugs directly into parasite cells, reducing the curative dose by 100-fold and circumventing drug resistance. This high-tech approach has the potential to reverse resistance to many first-line treatments for infectious diseases.
A new study finds that calcineurin is essential for malaria parasites to invade red blood cells. The protein allows the parasite to recognize and attach to the red blood cell surface, and inhibitors of calcineurin can prevent infection.
A months-long literature search uncovered evidence that a microscopic aquatic parasite, Blastulidium paedophthorum, is a widespread and virulent multi-host parasite in southeastern Michigan lakes. The research found that the parasite significantly impacts host fecundity without reducing Daphnia lifespan.
Researchers have discovered a new and promising target site for a potential vaccine against malaria, a mosquito-borne illness that kills hundreds of thousands each year. The AnAPN1 protein is believed to be central to the transmission of the malaria parasite through mosquitoes.
Researchers uncover detailed information on AnAPN1 protein shape and antibody binding sites, enabling the design of more effective mosquito-based vaccines. This breakthrough may lead to a reduced number of infected mosquitoes and eventual disease eradication.
A two-year study on bumble bees in Alaskan agricultural areas reveals declining populations of the western bumble bee species Bombus occidentalis, which is infected with Nosema and social parasites. The research provides baseline data for understanding reported patterns of bumble bee declines in North America.
A University of South Florida study confirms the dilution effect hypothesis, suggesting biodiversity loss poses a public health threat by causing disease outbreaks. The research found broad evidence that species-rich communities suffer less infectious disease, implying maintaining biodiversity could reduce parasite abundance.
A new study published in PLOS Pathogens reveals that malaria parasites growing in different host cells can develop resistance to antimalarial drugs. Researchers found that the metabolic state of red blood cells provides a unique environment for Plasmodium parasites, allowing them to scavenge essential resources and evade drug targeting.
Researchers have identified two genetically divergent subpopulations of P. knowlesi in human cases, each associated with a different species of reservoir host. This discovery highlights the complexity of zoonotic malaria transmission and may lead to new possibilities for parasite adaptation to humans.
A new study uses 3D printed eggs to test how birds identify and reject parasitic eggs with greater precision. Researchers found that robins accepted 100% of blue-green eggs but rejected 79% of cowbird-like eggs, similar to past studies but with less variability and precise reproduction.
A study found that physical contact during social grooming increases the risk of gastrointestinal parasites in brown spider monkeys. The researchers analyzed data from 12 individual monkeys and found a strong correlation between grooming interactions and parasite infections, particularly with roundworms Strongyloides and Trichostrongylus.
Researchers at UTMB have successfully tested a vaccine for Chagas disease, which can provide long-lasting immunity in animal models. The vaccine was found to significantly reduce parasite levels and prevent chronic symptoms, making it a promising tool for control of this infection.
A candidate vaccine has been shown to induce long-lasting immunity against the parasite that causes Chagas disease. Mice vaccinated with a combination of two parasite proteins showed reduced parasite numbers and improved immune response compared to uninfected mice.
Researchers at Harvard T.H. Chan School of Public Health have identified a critical host factor, CD55, that enables the malaria parasite to invade human red blood cells. The discovery opens up new avenues for developing therapies to treat and prevent malaria.
Researchers have identified a way for malaria parasites to dodge anti-malarial drugs, surviving inside immature red blood cells and remaining sensitive to certain treatments. This finding may help guide future research and lead to the development of new anti-malarial drugs for refractory patients.
A study by Lisa White and colleagues found that parasite half-life is a key predictor of artemisinin-resistant malaria, but the current definition of resistance is inaccurate. The researchers suggest refining the definition to account for parasite load at the start of treatment.
Researchers developed a model of a malaria-infected red blood cell to understand the mechanism behind stiffening and stickiness. The model found that protein nodules called knobs contribute to stiffness, suggesting a promising approach to treat the disease by softening the cells.
Researchers found that bumblebees infected with the Crithidia bombi parasite were more likely to consume nicotine-laced nectar, delaying parasite progression. However, consuming nicotine had negative effects, suppressing the appetite of infected bees and reducing healthy bee lifespan.
Researchers discover that artemisinin treatment can be effective against resistant malaria parasites by extending treatment duration or using proteasome inhibitors, which cause cellular stress and damage protein degradation. The study provides new hope for preventing the spread of drug resistance in Southeast Asia.
Researchers discovered that combining artemisinins with a low dose of an anti-cancer drug can increase the effectiveness of anti-malarial drugs and overcome the parasite's defences. This finding has the potential to combat resistant malaria parasites, which are currently spreading globally.
Researchers at London School of Hygiene & Tropical Medicine discovered a genetic mutation in the ap2mu gene that makes Plasmodium falciparum malaria parasites less susceptible to artemisinin and quinine. This finding suggests a different route to drug resistance may be developing independently in Africa.
Researchers at Notre Dame have made a breakthrough discovery in understanding the mechanism of artemisinin resistance in malaria. They found that a specific lipid called phosphatidylinositol-3-phosphate (PI3P) is produced by an enzyme called PfPI3K, and its levels are linked to artemisinin resistance.
A new study found that 79% of southeast African birds were infected with haemosporidian parasites, including novel malaria parasite lineages. The study's findings indicate that lifestyle characteristics of birds can influence their association with different parasite genera.
Researchers tracked protein coats on sleeping sickness parasite, finding up to 80 distinct disguises present at any time. This challenges conventional understanding of antigenic variation and its role in parasite survival.
A study published in Science Advances reveals that co-infection with two parasite species can reduce the severity of a more lethal disease, East Coast fever. The researchers propose using a mild parasitic infection as a vaccine alternative, which could be safer and less costly.
African cattle infected with the deadly East Coast fever parasite are less likely to die when co-infected with its milder cousin. The findings suggest a protective process that could also be at work in human malaria, where infections with milder parasites may protect against severe disease.
A new study found that a parasite significantly increases cannibalism among freshwater shrimp in Northern Ireland. Infected shrimp become voracious and consume their victims twice as much as uninfected animals. The research suggests that the parasite may be weakening the shrimp's resistance to invasive species.
IU scientists have discovered a new way the parasite Toxoplasma gondii modifies brain cells, which may help explain changes in the behavior of mice and potentially influence human behavior. The findings suggest that Toxoplasma infection could alter human behavior, with some research suggesting an association with schizophrenia.
Researchers discovered that brain swelling is the cause of death in children with cerebral malaria, which may lead to new treatments targeting the swelling. The study's findings could help reduce mortality rates from malaria in Africa, where the disease still claims thousands of lives each year.
Researchers from Karolinska Institutet identified the key role of RIFIN protein in protecting blood type O individuals from severe malaria. The protein binds strongly to A blood cells but weakly to O, explaining why O individuals are less susceptible to the disease.
Researchers from the University of South Florida have discovered how malaria parasites replicate their chromosomes up to thousands of times before spinning off into daughter cells. This understanding could lead to a powerful new treatment for malaria-caused illnesses, which kill over 600,000 people annually.
Researchers developed ultra-sensitive detection methods for malaria parasites, detecting 58% of infections in human blood samples at low concentrations. The new assays surpass current standards, identifying 16% more cases and reducing false negatives.
Researchers sequenced and analyzed the genome of a specific hookworm species to discover new information for treating parasitic infections. They identified unique protein families, such as ASPRs, that may block the host's immune response, paving the way for potential new treatments.
A recent study by researchers at The Sainsbury Laboratory has shed new light on the evolution of plant diseases using a generalist parasite, Albugo candida. The parasite's ability to suppress host immunity allows it to adapt to different host species and expand its range.
Researchers at Hebrew University of Jerusalem discover malaria parasite uses long noncoding RNA to switch genes and evade human immune system. They develop novel method to suppress virulence genes, breaking code of its immune evasion.
Researchers at University of British Columbia discover that parasites in the apicomplexan family evolved to become parasites earlier than thought, with some relatives being photosynthetic algae. Advanced genomic analysis and observations of cell structure and behavior reveal a more complex evolutionary history.
Virginia Tech biochemists identify PCNA as a key protein in the sleeping sickness parasite's life cycle, suggesting multiple ways to disrupt its function. This discovery could lead to the development of new drugs to curb the disease, which affects millions worldwide.
A study found that diverse small predators, like dragonfly larvae, reduce parasitic flatworm infections in frogs. The research suggests a link between dwindling global biodiversity and increased infectious diseases.
A study by USF biologists reveals that an abundance of predators can help control parasite transmission in amphibians, potentially reducing disease risk. The researchers identified a key trait of predators that predicts their ability to dilute disease risk.
Scientists at University of California - San Diego School of Medicine developed a malaria parasite protein produced by algae, generating antibodies in mice that nearly eliminated mosquito infection. The method uses an affordable and environmentally friendly approach to prevent malaria transmission from host to mosquito.
A UNL researcher highlights the impact of climate change on the emergence of infectious diseases, citing examples of West Nile virus and Ebola as predictable outcomes. The expert calls for greater collaboration between public and veterinary health communities to address the growing threat.
Researchers are using satellite data to target deadly parasites by identifying areas where disease flourishes. The project combines skills from various scientists to create maps accessible to countries with limited capacity for managing disease data.
A new study led by University of Maryland School Medicine researcher Joana C. Silva found that five common Plasmodium species have not changed which animals they infect for at least 3 million years. This suggests that host switching by malaria-causing parasites is not a common event on an evolutionary time scale.
Researchers at Albert Einstein College of Medicine have developed a novel yeast-based high-throughput assay to identify inhibitors of the Plasmodium falciparum transporter, which could lead to the development of new antimalarial drugs. The technique was used to screen over 64,000 compounds and identified 171 potential antimalarial drugs.
The University of Melbourne-led study cracks the genetic code of T. canis, revealing its molecular biology and providing valuable insights into combating deadly outbreaks. The findings will aid future research on other related parasites, improving global health outcomes.
Eve, an AI robot scientist, has demonstrated the success of its approach to speed up drug discovery and make it more economical. It discovered a compound that has anti-cancer and malaria properties, which could potentially improve the lives of millions of people worldwide.
A new study finds that muskrats and minks in central Illinois have high rates of toxoplasmosis, a parasite spread by cats. The researchers suspect tile drainage systems and lack of natural wetlands in the area are contributing to the disease's spread.
Researchers identified 32% of parasites found in rats also infecting humans, highlighting the importance of habitat overlap and species relationships. The study developed a new modeling approach to forecast parasitic infections and disease emergence globally.
A new study from University of Michigan researchers reveals that competition between predators and parasites can strengthen biological control systems, rather than weaken them. This counterintuitive finding has potential applications for organic farming and pest control, where synthetic pesticides are not allowed.
A genome-wide study of the malaria parasite reveals a complex genetic architecture that enables artemisinin resistance. Researchers found 20 mutations in the kelch13 gene and four other genes that work together to support resistance, but monitoring specific genetic backgrounds could help target high-risk regions.
Schistosomiasis, caused by a water-born parasite, affects 200 million globally. A new software, QDREC, helps find an effective treatment by automating the drug-discovery process.
A recent study by Ria Ghai has identified three genetically distinct groups of whipworms, with only one being transmissible between humans and non-human primates. This discovery has significant public health implications and highlights the need for conservation efforts to protect endangered species.